Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Pieber

Showing results (41-50 of 322) with videos related to

Pageof 33
Sort By:
Advances in Therapy|April 20, 2020
Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U300 in the Netherlands: Evidence From a Randomised Controlled TrialMarc Evans, Robert G J Moes, Katrine S Pedersen, et al.
Endocrinology, Diabetes & Metabolism Case Reports|September 18, 2015
Fluconazole and acetazolamide in the treatment of ectopic Cushing's syndrome with severe metabolic alkalosisVerena Schwetz, Felix Aberer, Claudia Stiegler, et al.
Analytical and Bioanalytical Chemistry|November 22, 2013
Recirculation--a novel approach to quantify interstitial analytes in living tissue by combining a sensor with open-flow microperfusionLukas Schaupp, Franz Feichtner, Roland Schaller-Ammann, et al.
Diabetes Technology & Therapeutics|July 12, 2021
Immunogenicity of the Novel Glucagon Analogue Dasiglucagon: Results of a Dedicated Immunogenicity Trial in Type 1 DiabetesThomas R Pieber, Olubukola Ajala, Oren Steen, et al.
Metabolism: Clinical and Experimental|November 17, 2009
Association of FTO gene with hyperandrogenemia and metabolic parameters in women with polycystic ovary syndromeElisabeth Wehr, Natascha Schweighofer, Reinhard Möller, et al.
Diabetes, Obesity & Metabolism|February 17, 2018
The co-formulation of insulin degludec and insulin aspart lowers fasting plasma glucose and rates of confirmed and nocturnal hypoglycaemia, independent of baseline glycated haemoglobin levels, disease duration or body mass index: A pooled meta-analysis of phase III studies in patients with type 2 diabetesMartin Haluzík, Greg Fulcher, Thomas R Pieber, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 24, 2007
The impact of large tidal volume ventilation on the absorption of inhaled insulin in rabbitsAstrid H Petersen, Torben Laursen, Bo Ahrén, et al.
Diabetes, Obesity & Metabolism|March 24, 2022
Efficacy, safety, tolerability, and noninferiority phase 3 study of glucagon as a ready-to-use room temperature liquid stable formulation versus a lyophilised formulation for the biochemical recovery and symptomatic relief of insulin-induced severe hypoglycaemia in adults with type 1 diabetesThomas R Pieber, Ronnie Aronson, Mark P Christiansen, et al.
Diabetes Technology & Therapeutics|February 3, 2011
Prediction of glucose concentration in post-cardiothoracic surgery patients using continuous glucose monitoringLukas Schaupp, Johannes Plank, Gerd Köhler, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2011
The lipid accumulation product is associated with impaired glucose tolerance in PCOS womenElisabeth Wehr, Hans-Jürgen Gruber, Albrecht Giuliani, et al.
Pageof 33

Showing results (41-50 of 322) with videos related to

Sort By:
Pageof 33
Advances in Therapy|April 20, 2020
Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U300 in the Netherlands: Evidence From a Randomised Controlled TrialMarc Evans, Robert G J Moes, Katrine S Pedersen, et al.
Endocrinology, Diabetes & Metabolism Case Reports|September 18, 2015
Fluconazole and acetazolamide in the treatment of ectopic Cushing's syndrome with severe metabolic alkalosisVerena Schwetz, Felix Aberer, Claudia Stiegler, et al.
Analytical and Bioanalytical Chemistry|November 22, 2013
Recirculation--a novel approach to quantify interstitial analytes in living tissue by combining a sensor with open-flow microperfusionLukas Schaupp, Franz Feichtner, Roland Schaller-Ammann, et al.
Diabetes Technology & Therapeutics|July 12, 2021
Immunogenicity of the Novel Glucagon Analogue Dasiglucagon: Results of a Dedicated Immunogenicity Trial in Type 1 DiabetesThomas R Pieber, Olubukola Ajala, Oren Steen, et al.
Metabolism: Clinical and Experimental|November 17, 2009
Association of FTO gene with hyperandrogenemia and metabolic parameters in women with polycystic ovary syndromeElisabeth Wehr, Natascha Schweighofer, Reinhard Möller, et al.
Diabetes, Obesity & Metabolism|February 17, 2018
The co-formulation of insulin degludec and insulin aspart lowers fasting plasma glucose and rates of confirmed and nocturnal hypoglycaemia, independent of baseline glycated haemoglobin levels, disease duration or body mass index: A pooled meta-analysis of phase III studies in patients with type 2 diabetesMartin Haluzík, Greg Fulcher, Thomas R Pieber, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 24, 2007
The impact of large tidal volume ventilation on the absorption of inhaled insulin in rabbitsAstrid H Petersen, Torben Laursen, Bo Ahrén, et al.
Diabetes, Obesity & Metabolism|March 24, 2022
Efficacy, safety, tolerability, and noninferiority phase 3 study of glucagon as a ready-to-use room temperature liquid stable formulation versus a lyophilised formulation for the biochemical recovery and symptomatic relief of insulin-induced severe hypoglycaemia in adults with type 1 diabetesThomas R Pieber, Ronnie Aronson, Mark P Christiansen, et al.
Diabetes Technology & Therapeutics|February 3, 2011
Prediction of glucose concentration in post-cardiothoracic surgery patients using continuous glucose monitoringLukas Schaupp, Johannes Plank, Gerd Köhler, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2011
The lipid accumulation product is associated with impaired glucose tolerance in PCOS womenElisabeth Wehr, Hans-Jürgen Gruber, Albrecht Giuliani, et al.
Pageof 33